scispace - formally typeset
T

Tianzhong Li

Researcher at City University of Hong Kong

Publications -  12
Citations -  109

Tianzhong Li is an academic researcher from City University of Hong Kong. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 3, co-authored 5 publications receiving 42 citations.

Papers
More filters
Journal ArticleDOI

Adhesion of Microdroplets on Water-Repellent Surfaces toward the Prevention of Surface Fouling and Pathogen Spreading by Respiratory Droplets

TL;DR: The results suggested that the adhesion of microdroplets should be duly considered in the design and application of water-repellent surfaces on biofouling prevention.
Journal ArticleDOI

A CRISPR/Cas12a-empowered surface plasmon resonance platform for rapid and specific diagnosis of the Omicron variant of SARS-CoV-2

TL;DR: MOPCS is a low-cost, CRISPR/Cas12a-system-empowered SPR gene-detecting platform that can analyze viral RNA, without the need for amplification, within 38 min from sample input to results output, and achieve a limit of detection of 15 fM.
Journal ArticleDOI

Self-assembled Lipid Nanoparticles for Ratiometric Codelivery of Cisplatin and siRNA Targeting XPF to Combat Drug Resistance in Lung Cancer.

TL;DR: The results demonstrate an effective approach to utilize a multi-targeted nanoparticle system that can specifically silence an NER-related gene to promote apoptosis induced by cisplatin, especially in cisPlatin-refractory tumors.
Journal ArticleDOI

The rise of AI optoelectronic Sensors: from nanomaterial synthesis, device design to practical application

TL;DR: In this paper , an overview of the progress, applications, and prospects of AI optoelectronic sensing technology is presented, that is, toward all-weather, versatile, and intelligent systems in the age of AI/IoT.
Journal ArticleDOI

Glioma diagnosis and therapy: Current challenges and nanomaterial-based solutions.

TL;DR: Glioma is often referred to as one of the most dreadful central nervous system (CNS)-specific tumors with rapidly-proliferating cancerous glial cells, accounting for nearly half of the brain tumors at an annual incidence rate of 30-80 per a million population as discussed by the authors .